Bulletin

WHO

Disease Outbreak News: Anthrax - Zambia

December 8, 2023

WHO

WHO appeals for protection of the health system from further attacks and degradation of its capacity

December 5, 2023

Roche

Roche announces positive Phase III results for inavolisib combination in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation

December 5, 2023

Roche

Roche expands hepatitis diagnostics portfolio to help clinicians diagnose and monitor patients with acute or chronic hepatitis B infection

November 27, 2023

WHO

WHO leads very high-risk joint humanitarian mission to Al-Shifa Hospital in Gaza

November 18, 2023

WHO

New WHO campaign highlights tobacco industry tactics to influence public health policies

November 16, 2023

Press Information Bureau

National Health Authority (NHA) organises Accelerator Workshops on ABDM Integration and NHCX Adoption in association with IRDAI

November 14, 2023

Roche

Roche’s subcutaneous injection of Tecentriq recommended by the EU’s CHMP for multiple cancer types

November 14, 2023

WHO

WHO loses communication with contacts in Al-Shifa hospital in Gaza amid reports of attacks

November 12, 2023

WHO

Tuberculosis response recovering from pandemic but accelerated efforts needed to meet new targets - embargoed until 16.00 on 07 November

November 7, 2023

WHO

WHO welcomes decision by Egypt to receive patients from Gaza Strip

November 2, 2023

Press Information Bureau

Significant Achievement under Special Campaign 3.0 in Department of Health and Family Welfare

November 1, 2023

Roche

Roche announces EMBARK trial in Duchenne muscular dystrophy (DMD) did not reach primary endpoint, but shows positive efficacy outcomes on all timed functional key endpoints

November 1, 2023

WHO

WHO outlines crucial research priorities for better refugee and migrant health

October 30, 2023

Roche

FDA approves Roche’s Vabysmo for the treatment of retinal vein occlusion (RVO)

October 27, 2023

Roche

Positive topline phase III results show Roche's Vabysmo improved vision for people living with retinal vein occlusion (RVO)

October 27, 2023

< 1 … 33 34 35 36 37 38 39 40 41 … 94 >

Bulletin

Disease Outbreak News: Anthrax - Zambia

WHO appeals for protection of the health system from further attacks and degradation of its capacity

Roche announces positive Phase III results for inavolisib combination in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation

Roche expands hepatitis diagnostics portfolio to help clinicians diagnose and monitor patients with acute or chronic hepatitis B infection

WHO leads very high-risk joint humanitarian mission to Al-Shifa Hospital in Gaza

New WHO campaign highlights tobacco industry tactics to influence public health policies

National Health Authority (NHA) organises Accelerator Workshops on ABDM Integration and NHCX Adoption in association with IRDAI

Roche’s subcutaneous injection of Tecentriq recommended by the EU’s CHMP for multiple cancer types

WHO loses communication with contacts in Al-Shifa hospital in Gaza amid reports of attacks

Tuberculosis response recovering from pandemic but accelerated efforts needed to meet new targets - embargoed until 16.00 on 07 November

WHO welcomes decision by Egypt to receive patients from Gaza Strip

Significant Achievement under Special Campaign 3.0 in Department of Health and Family Welfare

Roche announces EMBARK trial in Duchenne muscular dystrophy (DMD) did not reach primary endpoint, but shows positive efficacy outcomes on all timed functional key endpoints

WHO outlines crucial research priorities for better refugee and migrant health

FDA approves Roche’s Vabysmo for the treatment of retinal vein occlusion (RVO)

Positive topline phase III results show Roche's Vabysmo improved vision for people living with retinal vein occlusion (RVO)

Company

Resources